期刊
AGEING RESEARCH REVIEWS
卷 67, 期 -, 页码 -出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.arr.2021.101303
关键词
Otubains; OTUB1; OTUB2; Cancers; Diseases
资金
- National Natural Science Foundation of China [317006862, 81825014, 31830003]
Otubains, initially identified as DUBs, have emerged as essential regulators of various physiological processes and are associated with an increased risk of aging-related diseases such as cancers, neurodegenerative disorders, chronic kidney diseases, bone dysplasia, and pulmonary fibrosis. They are aberrantly expressed in cancers and may act as both tumor suppressors and promoters in different types of cancers.
OTU domain-containing ubiquitin aldehyde-binding proteins Otubain1 (OTUB1) and Otubain2 (OTUB2) were initially identified as OTU deubiquitinases (DUBs). Recently, Otubains have emerged as essential regulators of diverse physiological processes, such as immune signaling and DNA damage response. Dysregulation of those processes is likely to increase the risk in multiple aspects of aging-related diseases, including cancers, neurodegenerative disorders, chronic kidney diseases, bone dysplasia and pulmonary fibrosis. Consistently, Otubains are aberrantly expressed in cancers and have been identified to be both tumor suppressors and tumor promoters in different types of cancers. Therefore, the regulatory mechanism of the activity and expression of Otubains is very important for better understanding of Otubains-associated biological networks and human diseases. This review provides a comprehensive description of functions and regulatory axis of Otubains, highlighting experimental evidences indicating Otubains as potential therapeutic targets against aging-related disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据